Logo

Dykes Fills Variagenics' New Genomics Position

Nov 14, 1998
Premium

CAMBRIDGE, Mass.--Variagenics announced the appointment of Colin Dykes to the newly created position of vice-president, genomics. Dykes had a 16-year career at Glaxo Wellcome before joining Variagenics, a firm here that identifies clinically important variances in genes that affect drug action. Dykes established Glaxo's first genetics and genomics programs and most recently served as director of its UK Genetics Division. At Variagenics, Dykes will lead research and development in genomics and pharmacogenomics.

Filed under

Informatics
Breaking News
The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.